Articles From: LiveDeal Inc., Launches livedeal.com in San Francisco, CA to Daclatasvir Marketing Authorization Application for Treatment of Chronic Hepatitis C Validated for Accelerated Regulatory Review by the European Medicines Agency


2014/1/9
http://media.marketwire.com/attachments/201207/64160_livedeal-logo1.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1080520&ProfileId=051205&sourceType=1 LAS VEGAS, NV --
Sign-up for LiveDeal Inc., Launches livedeal.com in San Francisco, CA investment picks
2014/1/9
By Barbara Kollmeyer, MarketWatch MADRID (MarketWatch) -- Marks & Spencer Group PLC stood out with gains on a mostly losing day for retailers after more downbeat news over Christmas sales, while the Bank of England's Monetary Policy Committee held tight on interest rates and quantitative easing on Thursday.
Sign-up for LONDON MARKETS: Another Down Retailer Day In London; BOE Holds Steady investment picks
2014/1/9
CHARLOTTE, N.C., Jan.
Sign-up for Mathematica Policy Research Partners With Premier, Inc. to Implement Learning System for ACOs investment picks
2014/1/9
COLUMBIA, Md.
Sign-up for MICROS Names Carlos Echalar as Chief Human Resources Officer investment picks
2014/1/9
SAN DIEGO, Jan.
Sign-up for Mitek to Present at 16th Annual Needham Growth Conference investment picks
2014/1/9
NEW YORK, Jan.
Sign-up for New York Mortgage Trust Announces Exercise of Underwriters' Option to Purchase Additional Shares investment picks
2014/1/9
DETROIT , Jan.
Sign-up for Non-Profit Leader to Oversee DTE Energy Foundation and Public Affairs investment picks
2014/1/9
By Marta Falconi ZURICH-Diovan, the anti-hypertension treatment at the heart of Novartis AG's (NOVN.VX) troubles in Japan, is raising blood pressure at the pharmaceutical giant for another reason: The blockbuster drug is hemorrhaging sales.
Sign-up for Novartis's Blockbuster Drug Hemorrhages Sales investment picks
2014/1/9
WALL, N.J., Jan.
Sign-up for SchoolWheels Direct Signs New Management Services Agreement investment picks
2014/1/9
Intimate Apparel Retailer Launches Its Next Giving is Beautiful™ Soma Bra Donation NEW YORK , Jan.
Sign-up for Soma Intimates: Helping Support Women in Need investment picks
2014/1/9
STILLWATER, Okla., Jan.
Sign-up for Southwest Bancorp, Inc. Announces Schedule for Fourth Quarter 2013 Earnings Release and Conference Call investment picks
2014/1/9
NEW YORK (MarketWatch) -- Supervalu Inc. (SVU) said Thursday its fiscal third-quarter profit rose to $31 million, or 12 cents a share, from $16 million, or 8 cents a share, a year earlier.
Sign-up for Supervalu third-quarter profit rises, sales fall investment picks
2014/1/9
Wall Street appeared to be in a confident mood on Thursday, with stock futures pointing to at least a positive start for markets, with interest-rate decisions due to be handed down in the U.K. and the euro zone.
Sign-up for U.S. Stock Futures Rise investment picks
2014/1/9
BLUE BELL, Pa.
Sign-up for Unisys Announces Date of Fourth-Quarter and Full-Year 2013 Financial Results and Conference Call investment picks
2014/1/9
Unum Group (NYSE: UNM) will release its fourth quarter results on Tuesday, Feb.
Sign-up for Unum Group to release fourth quarter 2013 results and host conference call investment picks
2014/1/9
By Jeanette Pavini They are two of the most popular New Year's resolutions: To lose weight and to save money.
Sign-up for UPDATE: Get the best deal on your gym membership investment picks
2014/1/9
EL PASO, Texas, Jan.
Sign-up for Western Refining, Inc. Announces Fourth Quarter and Full Year 2013 Earnings Conference Call investment picks
2014/1/9
OVERLAND PARK, Kan., Jan.
Sign-up for YRC Worldwide Reviewing Options After Unsuccessful MOU Vote investment picks
2014/1/9
21st Century Fox Inc. (FOXA) has begun the process to remove its listing on the Australian Securities Exchange, which the company said was an attempt to simplify the entertainment company's operating and capital structure.
Sign-up for 21st Century Fox To Delist From Australian Market investment picks
2014/1/8
Amphenol now offers rugged CTF media converters from DC to 10Gbps supporting multiple protocols for the military, aerospace and industrial markets.
Sign-up for Amphenol Aerospace Operations (AAO) High Speed Solutions (HSS) Division Offers Rugged Copper to Fiber (CTF) Media Converter Products investment picks
2014/1/8
Bank of the Ozarks, Inc. (NASDAQ: OZRK) expects to report fourth quarter and full year 2013 earnings at the close of business Thursday, January 16, 2014.
Sign-up for Bank of the Ozarks, Inc. Announces Fourth Quarter and Full Year 2013 Earnings Release Date and Conference Call and Announces Date of 2014 Annual Shareholders’ Meeting investment picks
2014/1/8
Barracuda Backup 190 and 390 Now Available as Affordable Annual Subscription Services CAMPBELL, Calif.
Sign-up for Barracuda Networks Launches Backup-as-a-Service investment picks
2014/1/8
http://media.marketwire.com/attachments/201210/90690_Cisco_logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1080164&ProfileId=051205&sourceType=1 LAS VEGAS, NV --
Sign-up for Cisco Study Says Internet of Everything (IoE) Can Create Savings, Increase Productivity and Revenue for Governments Globally, While Improving Citizen Benefits Over the Next Decade investment picks
2014/1/8
ClearBridge Energy MLP Opportunity Fund Inc. (NYSE:EMO) announced today the unaudited statement of assets and liabilities, the net asset value and asset coverage ratio of the Fund as of December 31, 2013.
Sign-up for ClearBridge Energy MLP Opportunity Fund Inc. Announces Unaudited Balance Sheet Information as of December 31, 2013 investment picks
2014/1/8
"Monsanto Profit Rises 8.6% on Stronger Sales" at 8:44 a.m. EST incorrectly said corn seed and traits segment sales rose 7.5% to $1.05 billion.
Sign-up for Correction to Monsanto Earnings Story investment picks
2014/1/8
Bristol-Myers Squibb Company (NYSE:BMY) today announced that the European Medicines Agency (EMA) has validated the company’s marketing authorization application (MAA) for the use of daclatasvir (DCV), an investigational NS5A complex inhibitor, for the treatment of adults with chronic hepatitis C (HCV) with compensated liver disease, including genotypes 1, 2, 3, and 4.
Sign-up for Daclatasvir Marketing Authorization Application for Treatment of Chronic Hepatitis C Validated for Accelerated Regulatory Review by the European Medicines Agency investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: LiveDeal Inc., Launches livedeal.com in San Francisco, CA to Daclatasvir Marketing Authorization Application for Treatment of Chronic Hepatitis C Validated for Accelerated Regulatory Review by the European Medicines Agency
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity